Pancreatic lipase inhibitors prevent the breakdown of dietary fat into fatty acids, thereby reducing their absorption in the gut. This action makes them attractive for use as antiobesity drugs. Currently, a few drugs have been approved by the Food and Drug Administration (FDA) for long-term use in the management of obesity. Over the last decades, studies have shown that many plants exhibit pancreatic lipase inhibitor activity in their extracts. The present review highlights the current status of our knowledge about lipase inhibitory activity in molecules derived from plant sources. We could possibly have a range of natural products derived from plants that could be of use in the treatment of obesity.
INTRODUCTION
Obesity is recognized as a major public health concern at the global level by the World Health Organization. It is related to a number of serious and potentially fatal diseases (Fig. 1) .
1,2 A number of drugs for the treatment of obesity have been tried with varying results and adverse side effects (Table 1) . Inhibition of dietary triglyceride absorption by inhibiting pancreatic lipase is an effective approach for the management of obesity (Fig. 2) . Tetrahydrolipstatin (orlistat), a saturated derivative of lipstatin, which is a potent inhibitor of gastrointestinal lipase, has been approved by the FDA. However, it has severe side effects. So, discovery of other lipase inhibitors from natural sources, namely plants, which could have minimal side effects, is an attractive area of research. A number of plants have been reported as sources of pancreatic lipase inhibitory molecules (Fig. 3 ).
Our present knowledge about plants as sources of lipase inhibitors, which could be used as antiobesity agents after proper clinical trials, is summarized in the following paragraphs.
GENERAL PLANTS
Various herbs and plants have been reported as having pancreatic lipase inhibitory activity (Fig. 4 ). Ado et al ritiana Lam bark powder (ZMBP) on high-fat-diet-induced obesity in a study done on rats. The dual-energy X-ray absorptiometry analysis was carried out for 90 days; at the end of this treatment, it showed a reduction in body weight over the standard drug treatment; it was due to the polyphenolic compound of ZMBP. Morikawa et al 
ACTIVE COMPONENT AND POTENTIAL ANTIOBESITY AGENTS
A wide range of plants have been reported for pancreatic lipase inhibitory activity and, in some cases, active components have been identified (Table 2 ). Nakai et al 
CONCLUSION
An overview of current literature about the plant sources of pancreatic lipase inhibitors has been presented. So far, the results have been very encouraging. In due course of time, lot of new antiobesity drugs derived from plant sources, which are potent and safe pancreatic lipase inhibitors, are likely to be found and after due clinical trials, these will be put into clinical practice. Hopefully, they will be effective and free of serious side effects.
